Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients
PDF | HTML | How to cite
Metrics: PDF 1457 views | HTML 2164 views | ?
Kai Qian1,2, Kai Guo1,2, Xiaoke Zheng1,2, Tuanqi Sun1,2, Duanshu Li1,2, Yi Wu1,2, Qinghai Ji1,2 and Zhuoying Wang1,2
1Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Department of Oncology, Fudan University Shanghai Medical College, Shanghai 200032, China
Zhuoying Wang, email: [email protected]
Keywords: screening criteria, active surveillance, papillary thyroid microcarcinoma, prognostic indicators, retrospective study
Received: March 14, 2017 Accepted: June 30, 2017 Published: July 22, 2017
Screening out patients who do not require immediate surgery is a growing trend in the field of thyroid research. In this study, we retrospectively compared the application of two surveillance selection criteria in 1001 patients who had undergone surgical treatment of papillary thyroid microcarcinoma (PTMC): low-risk PTMC characteristics defined by Kuma Hospital and CATO consensus on PTMC management of active surveillance. Treatment outcomes were compared between groups. We then analyzed the prognostic indicators of patients who could be managed by surveillance. A total of 724 patients met Kuma screening criteria and 135 met CATO screening criteria. The Kuma low-risk group had a lower incidence of multifocal lesions and CLNM than Kuma high-risk group. We also found more obvious differences in multifocal lesions, CLNM and extrathyroidal extension when evaluating the CATO low-risk criteria in the same manner. On the other hand, patients in the CATO low-risk group had a lower disease progression rate and longer disease-free survival than those in CATO high-risk group. There was no significant difference in prognosis between the Kuma low-risk group and Kuma high-risk group. Our logistic regression analysis showed that a preoperative ultrasound size of >5 mm, male sex, younger age, and malignant lesions without concurrent benign nodules could be predictors of CLNM. In conclusion, patients classified in CATO low-risk criteria had lower proportion of clinicopathological risk factors than the ones in Kuma low-risk criteria. We also found more risk factors may not be suitable for surveillance, such as tumors without concurrent benign nodules.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.